ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1694 • 2015 ACR/ARHP Annual Meeting

    All-Cause Mortality and Malignancies in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study

    Philip J. Mease1, Alice B. Gottlieb2, Alan Menter3, Christopher T. Ritchlin4, Sunil Kalia5, Francisco Kerdel6, Shelly Kafka7, James Morgan7, Wayne Langholff8, Steve Fakharzadeh7 and Kavitha Goyal7, 1Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, 2Tufts Medical Center and Tufts University School of Medicine, Boston, MA, 3Baylor Research Institute, Dallas, TX, 4Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY, 5University of British Columbia, Vancouver, BC, Canada, 6University of Miami, Miami, FL, 7Janssen Scientific Affairs, LLC, Horsham, PA, 8Janssen Research & Development, LLC, Spring House, PA

    Background/Purpose: Describe characteristics and incidence rates of all-cause mortality and malignancies (excluding NMSC) in psoriasis pts with psoriatic arthritis (PsA) from PSOLAR. Methods: PSOLAR is…
  • Abstract Number: 1695 • 2015 ACR/ARHP Annual Meeting

    Fatigue May be Independently Active at a Certain Part of Spondyloarthritis Patients: Hur-BIO Real Life Results

    Umut Kalyoncu1, Abdulsamet Erden1, Levent Kilic1, Emrah Seyhoglu2, Denizcan Güven2, Burak Yasin Aktas2, Yusuf Ziya Sener2, Omer Karadag1, Sule Apras Bilgen1, Ali Akdogan1, Sedat Kiraz1 and Ihsan Ertenli1, 1Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Fatigue is one of the essential patient reported outcome almost all inflammatory rheumatic diseases. However, fatigue may be affected from multidimensional factors such as…
  • Abstract Number: 1696 • 2015 ACR/ARHP Annual Meeting

    Score Classification Underestimates the Real Cardiovascular Risk in Psoriatic Arthritis Patients

    Maria Paz Martínez-Vidal1, Cristina Fernández-Carballido2, Francisca Sivera3, Raquel Martín-Doménech1, Nieves Martínez-Alberola1 and Alejandro San Martin4, 1Rheumatology, Hospital General Universitario Elda, ELDA, Spain, 2Rheumatology, Hospital General Universitario de Elda, Elda (Alicante), Spain, 3Reumatología, Hospital General Universitario de Elda, Alicante, Spain, 4Rheumatology, Univesity General Hospital, ELDA, Spain

    Background/Purpose: SCORE tables underestimate the Cardiovascular Risk (CVR) for patients with Rheumatoid Arthritis (RA) and EULAR recommends multiplying by 1.5 the CVR obtained from them…
  • Abstract Number: 1697 • 2015 ACR/ARHP Annual Meeting

    Obstructive Sleep Apnea and Fatigue in Inflammatory Arthritis Patients Taking TNF-Inhibitors

    Brian Breviu1, Tawnie Braaten1, Daniel Clegg2 and Jessica Walsh3, 1Department of Internal Medicine, Salt Lake City Veteran Affairs and University of Utah Medical Centers, Salt Lake City, UT, 2Rheumatology, Salt Lake City Veteran Affairs and University of Utah Medical Centers, Salt Lake City, UT, 3Rheumatology, Salt Lake City Veterans Affairs, Salt Lake City, UT

    Background/Purpose: Fatigue improves with TNF-inhibition (TNF-i) in people with inflammatory arthritis (IA), but the mechanistic relationships between TNF-i and fatigue are not well understood. Since…
  • Abstract Number: 1698 • 2015 ACR/ARHP Annual Meeting

    High Prevalence of Traditional Cardiovascular Risk Factors in an Ankylosing Spondylitis Cohort

    Gillian Fitzgerald1, Dara J Lundon2, Phil Gallagher3, Claire Sheehy4, Catherine Sullivan5, Carmel Silke6, Frances Stafford7, Killian O Rourke8, Muhammad Haroon9, Ronan Mullan10, Oliver FitzGerald11 and Finbar (Barry) O'Shea12, 1Rheumatology, St James's Hospital, Dublin 8, Ireland, 2School of Medicine, University College Dublin, Dublin, Ireland, 3Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, 4University Hospital Waterford, Waterford, Ireland, 5Rheumatology, UCHG Ireland, Galway, Ireland, 6Rheumatology, Sligo University Hospital, Sligo, Ireland, 7Rheumatology, Blackrock Clinic, Co Dublin, Ireland, 8Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland, 9Rheumatology, Kerry General Hospital, Co Kerry, Ireland, 10Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, 11St Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, St Vincent's University Hospital, Dublin 4, Dublin 4, Ireland, 12Rheumatology Dept, St James's Hospital, Dublin, Ireland

    Background/Purpose: Patients with Ankylosing Spondylitis (AS) have previously been considered an otherwise healthy patient population. However, emerging evidence suggests AS is an independent risk factor…
  • Abstract Number: 1699 • 2015 ACR/ARHP Annual Meeting

    Obesity and Pediatric Psoriatic Arthritis

    Cynthia Manos1, Timothy Brandon2, Rui Xiao3, Jon M. Burnham4 and Pamela F. Weiss1, 1Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 3Department of Pediatrics, Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, PA, 4Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose:   Studies in adults have shown a significant association between obesity and psoriatic arthritis. The association of obesity with pediatric psoriatic arthritis is unknown.…
  • Abstract Number: 1700 • 2015 ACR/ARHP Annual Meeting

    Subclinical Atherosclerosis in Ankylosing Spondylitis. Does It Really Exist and Which Are the Effects of Treatments? a Systematic Review

    Clément Prati1, Céline Demougeot2, Xavier Guillot2 and Daniel Wendling3, 1Service de Rhumatologie, CHRU J Minjoz, Besançon, France, 2EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche-Comté, Besançon, France, 3Université de Franche-Comté, Besançon, France

    Background/Purpose: Accelerated atherosclerosis and increased cardiovascular morbidity and mortality have been associated with ankylosing spondylitis (AS). Noninvasive angiological methods have been developped to evaluate endothelial…
  • Abstract Number: 1701 • 2015 ACR/ARHP Annual Meeting

    Long Term Outcome of Total Hip Replacement in Patients with Ankylosing Spondylitis

    Ana Lizarraga1, Natalia Zamora1, Graciela Betancur1, Luis Alejandro Cayetti2, Emilce Schneeberger2, Maria Celeste Orozco3, Fernando Andres Sommerfleck4 and Gustavo Citera3, 1Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: Total hip replacement (THR) surgery is a reliable therapeutic intervention for patients with severe hip involvement. The aim of our study was to determine…
  • Abstract Number: 1702 • 2015 ACR/ARHP Annual Meeting

    Osteoporosis in Psoriatic Arthritis

    Ali Aldei1, Shelly Chandran2, Suzanne Li2, Vinod Chandran3 and Dafna Gladman3, 1Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Psoriatic Arthritis (PsA) is an inflammatory arthritis affecting peripheral and axial joints in patients with psoriasis. The disease process in PsA comprises of complex…
  • Abstract Number: 1703 • 2015 ACR/ARHP Annual Meeting

    Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort

    Umut Kalyoncu, Levent Kilic, Abdulsamet Erden, Alper Sari, Berkan Armagan, Omer Karadag, Ali Akdogan, Sule Apras Bilgen and Ihsan Ertenli, Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Adipose tissue and adipokines are linked to inflammation. The relationship of obesity to rheumatologic disease activity is complex and recent studies demonstrate a connection…
  • Abstract Number: 1704 • 2015 ACR/ARHP Annual Meeting

    Prevalence of Obesity and Metabolic Syndrome in Patients with Axial Spondyloarthritis

    Graciela Betancur1, Maria Celeste Orozco2, Emilce Schneeberger2, Ana Lizarraga1, Natalia Zamora2, Fernando Andres Sommerfleck3 and Gustavo Citera2, 1Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Rheumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: Estimate the prevalence of Obesity (O) and Metabolic Syndrome (MS) in AxSpA and evaluate its association with sociodemographic and clinical variables. Methods: We included…
  • Abstract Number: 1705 • 2015 ACR/ARHP Annual Meeting

    Acute Anterior Uveitis in Ankylosing Spondylitis: Association with Inflammatory Bowel Disease and Psoriasis Independent of HLA-B27

    Ahmed Omar1, Tristan Boyd2, Ismail Sari1, Arane Thavaneswaran3, Renise Ayearst1, Robert D Inman4 and Nigil Haroon1, 1Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 2Rheumatology, University of California San Diego, La Jolla, CA, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Immunlogy and Institute of Medical Science, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Acute anterior uveitis (AAU) is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS), developing in 20-30% of these patients during the…
  • Abstract Number: 1706 • 2015 ACR/ARHP Annual Meeting

    Prevalence and Factors Associated with Non-Traumatic Vertebral Fractures in Psoriatic Arthritis

    Shelly Chandran1, Sindhu R. Johnson2, Angela Cheung3, David Salonen4 and Dafna Gladman5, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Dept of Rheumatology, Toronto Western and Mt. Sinai Hospitals, University of Toronto, Toronto, ON, Canada, 3Department of Medicine, University of Toronto, Toronto, ON, Canada, 4Department of Medical Imaging, University Health Network, Toronto, ON, Canada, 5Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: The prevalence of osteoporotic vertebral fractures (VF) in psoriatic arthritis (PsA) is not known. We aim to determine the prevalence and factors associated with…
  • Abstract Number: 1707 • 2015 ACR/ARHP Annual Meeting

    Comorbidity Burden and Medication Use Among Patients with Psoriatic Arthritis in the US

    Joseph F. Merola1, Simeng Han2, Jipan Xie2, Huaying Song2, Vivian Herrera3, Jin Wei2, Eric Q. Wu2 and Jacqueline B. Palmer3, 1Brigham and Women's Hospital, Boston, MA, 2Analysis Group, Inc., Boston, MA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease that is associated with various comorbidities. This study aimed to assess the comorbidity burden and medication…
  • Abstract Number: 1708 • 2015 ACR/ARHP Annual Meeting

    Predictors of Depression Severity in Ankylosing Spondylitis

    Mark Hwang1, MinJae Lee2, Michael M. Ward3, Lianne S. Gensler4, Matthew A. Brown5, Shervin Assassi6, Laura A. Diekman7, Mohammad H. Rahbar8, Michael H. Weisman9 and John D. Reveille10, 1Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, 2Biostatistics/Epidemiology/Research Design (BERD) Core | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, 3NIH/NIAMS, Bethesda, MD, 4Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 5The University of Queensland Diamantina Institute, Brisbane, Australia, 6Rheumatology, University of Texas Medical School at Houston, Houston, TX, 7Rheumatology, University of Texas Medical School, Houston, TX, 8The University of Texas Health Science Center at Houston, Houston, TX, 9Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 10Rheumatology, University of Texas Health Science Center at Houston, Houston, TX

    Background/Purpose: Depression is a known comorbidity of ankylosing spondylitis (AS) with over one-third of AS patients affected and increased depression-rate ratio compared to the general…
  • « Previous Page
  • 1
  • …
  • 1800
  • 1801
  • 1802
  • 1803
  • 1804
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology